These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11686527)

  • 1. The prognostic inhomogeneity in pT3 rectal carcinomas.
    Merkel S; Mansmann U; Siassi M; Papadopoulos T; Hohenberger W; Hermanek P
    Int J Colorectal Dis; 2001 Sep; 16(5):298-304. PubMed ID: 11686527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of pT sub-classification in surgical pathology of colorectal cancer.
    Pollheimer MJ; Kornprat P; Pollheimer VS; Lindtner RA; Schlemmer A; Rehak P; Langner C
    Int J Colorectal Dis; 2010 Feb; 25(2):187-96. PubMed ID: 19816699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Discussion on pT3 staging in TNM staging of AJCC 8(th) edition gallbladder carcinoma].
    Yang FC; Li JD; Duan AQ; Bo ZY; Shen NJ; Zhu B; Yu WL; Cui LJ; Wang X; Yu LH; Yin L; Fu XH; Zhang YJ; Qiu YH
    Zhonghua Wai Ke Za Zhi; 2019 Nov; 57(11):834-839. PubMed ID: 31694132
    [No Abstract]   [Full Text] [Related]  

  • 4. pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas-proposal for a new pT3a/pT3b subclassification.
    Foersch S; Lang-Schwarz C; Eckstein M; Geppert C; Schmitt M; Konukiewitz B; Groll T; Schicktanz F; Engel J; Gleitsmann M; Westhoff CC; Frickel N; Litmeyer AS; Grass A; Jank P; Lange S; Tschurtschenthaler M; Wilhelm D; Roth W; Vieth M; Denkert C; Nagtegaal I; Weichert W; Jesinghaus M
    Br J Cancer; 2022 Oct; 127(7):1270-1278. PubMed ID: 35864156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic inhomogeneity of colorectal carcinomas Stage III: a proposal for subdivision of Stage III.
    Merkel S; Mansmann U; Papadopoulos T; Wittekind C; Hohenberger W; Hermanek P
    Cancer; 2001 Dec; 92(11):2754-9. PubMed ID: 11753948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pT3 subclassification of renal pelvic cancer considering the tumor location improves the patients' prognostic accuracy.
    Sano T; Kato M; Sassa N; Sadachi R; Hirakawa A; Kamihira O; Hirabayashi T; Nishikimi T; Katsuno S; Kimura T; Hattori R; Gotoh M; Tsuzuki T
    Virchows Arch; 2021 Jun; 478(6):1089-1097. PubMed ID: 33420835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic subdivision of pT2 rectal carcinomas.
    Merkel S; Weber K; Brunner M; Baecker J; Agaimy A; Göhl J; Hohenberger W; Schellerer V; Grützmann R
    Int J Colorectal Dis; 2019 Mar; 34(3):409-415. PubMed ID: 30515557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of rectum carcinoma--experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma.
    Hermanek P; Wiebelt H; Staimmer D; Riedl S
    Tumori; 1995; 81(3 Suppl):60-4. PubMed ID: 7571056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.
    Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS
    Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.
    Shariat SF; Zigeuner R; Rink M; Margulis V; Hansen J; Kikuchi E; Kassouf W; Raman JD; Remzi M; Koppie TM; Bensalah K; Guo CC; Mikami S; Sircar K; Ng CK; Haitel A; Kabbani W; Chun FK; Wood CG; Scherr DS; Karakiewicz PI; Langner C
    Eur Urol; 2012 Aug; 62(2):224-31. PubMed ID: 22285763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reclassification of the current tumor, node, metastasis staging in pT3 renal cell carcinoma.
    Fujita T; Iwamura M; Yanagisawa N; Muramoto M; Okayasu I; Baba S
    Int J Urol; 2008 Jul; 15(7):582-6. PubMed ID: 18479355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice.
    Scosyrev E; Yao J; Messing E
    Urology; 2010 Oct; 76(4):908-13; discussion 914. PubMed ID: 20709375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of surgically treated bladder carcinoma with extravesical tumor extension.
    Quek ML; Stein JP; Clark PE; Daneshmand S; Miranda G; Cai J; Groshen S; Lieskovsky G; Quinn DI; Raghavan D; Skinner DG
    Cancer; 2003 Sep; 98(5):955-61. PubMed ID: 12942562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
    Bastian PJ; Hutterer GC; Shariat SF; Rogers CG; Palapattu GS; Lotan Y; Vazina A; Amiel GE; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP; Karakiewicz PI;
    BJU Int; 2008 Feb; 101(4):450-4. PubMed ID: 17850359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic inhomogeneity in pT3 rectal carcinomas: what are the clinical consequences?
    Mann B
    Int J Colorectal Dis; 2001 Sep; 16(5):305-6. PubMed ID: 11686528
    [No Abstract]   [Full Text] [Related]  

  • 17. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.
    Bouzourene H; Bosman FT; Seelentag W; Matter M; Coucke P
    Cancer; 2002 Feb; 94(4):1121-30. PubMed ID: 11920483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of pT3 colorectal carcinomas according to the depth of invasion.
    Bori R; Sejben I; Svébis M; Vajda K; Markó L; Pajkos G; Cserni G
    Pathol Oncol Res; 2009 Sep; 15(3):527-32. PubMed ID: 19172413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.
    Steuber T; Erbersdobler A; Graefen M; Haese A; Huland H; Karakiewicz PI
    Cancer; 2006 Feb; 106(4):775-82. PubMed ID: 16400637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microscopic and gross extravesical extension in pathological staging of bladder cancer.
    Quek ML; Stein JP; Clark PE; Daneshmand S; Miranda G; Cai J; Groshen S; Cote RJ; Lieskovsky G; Quinn DI; Skinner DG
    J Urol; 2004 Feb; 171(2 Pt 1):640-5. PubMed ID: 14713777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.